Andrada Mining acquisition elevates the miner to emerging mid-tier status. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Thursday newspaper round-up: Ireland, General Motors, GlaxoSmithKline

Thu, 18th Nov 2010 06:31

The Irish Government finally signalled yesterday that it may bow to international pressure and accept a multibillion-pound bailout, amid divisions in the Commons over whether Britain should contribute. While the details of any package may be several days away, there were growing signs that Britain could play a prominent role in any rescue, the Times reports.According to the Telegraph, a squad of inspectors from the EU and the International Monetary Fund will arrive in Dublin on Thursday to go through the books of the Irish banking system and prepare the way for a likely rescue of at least €80bn (£68bn). Olli Rehn, Europe's economics commissioner, said Ireland is not strong enough to back-stop a banking system that has been shut out of capital markets and suffered a haemorrhage of bank deposits.With the unemployment rate still above 13% and remaining high, many with a bankable trade are now considering taking the drastic option of leaving Ireland in search of work, the Independent adds. The government expects as many as 100,000 people to leave over the next four years.General Motors could raise almost $23bn (£14.5m) in the largest flotation in history when it rejoins the public market today. The carmaker said yesterday that it had increased the number of common shares it would sell from 365m to 478m, 412 million of which would come from the US Government. GlaxoSmithKline is close to securing formal US approval for the first new drug in 50 years to treat the complex autoimmune disease lupus, after experts recommended the release of the treatment despite broad safety concerns. The drug, known as Benlysta, is one of the most important new drugs in Glaxo's pipeline, says the Guardian. Britain's electricity market is braced for its biggest shake-up since privatisation as the Government prepares to unveil a package of measures designed to shore up £200 billion worth of investment in greener sources of energy over the next decade. The Times has learnt that David Cameron discussed the proposed changes on Monday with officials from the Treasury, the Department for Energy and Climate Change and Chris Huhne, the Energy Secretary.Business investment is bouncing back, according to the Bank of England, offering proof that the Government's private-sector led recovery is starting to bear fruit, the Telegraph reports. The Bank's November business conditions survey found that "investment plans over the next twelve months were more positive than outturns had been over the past twelve months", and that many companies "were gradually increasing capital spending". A multi-million pound investigation by the Office of Fair Trading into allegations of price fixing in the supermarket sector has been pulled in the latest blow to the embattled regulator, the Daily Telegraph says. The investigation has been quietly shelved after the Office of Fair Trading (OFT) failed to find sufficient evidence of wrongdoing. The OFT raided a number of supermarkets and consumer goods companies in April 2008 after receiving information suggesting possible price collusion. Dawn raids were launched at Tesco, Asda, Sainsbury's and Morrisons.Asda's plans to leapfrog Tesco to become the UK's biggest general merchandise retailer appear to be stalling after it admitted that it is set to open only two new Asda Living non-food stores in 2011. After unveiling just two shops this year, the Walmart-owned supermarket chain now has 25 Asda Living stores, which sell products such as its George clothing brand and homewares, the Independent says.BP's board will tighten its oversight of the company's day-to-day operations in the wake of the Gulf of Mexico oil spill, its chairman has said in his first big interview since the accident. Carl-Henric Svanberg, app­oint­ed chairman in January, said he did not consider resigning following the oil spill in April, in spite of criticism from some investors for not taking a more public role at the height of the crisis, the FT reports.
More News
23 Jun 2023 08:52

LONDON MARKET OPEN: Stocks down after BoE; GSK up on Zantac settlement

(Alliance News) - Stock prices in London opened lower on Friday, as rising interest rates weighed on housebuilding stocks in the FTSE 100.

Read more
23 Jun 2023 08:29

GSK reaches settlement in Goetz Zantac lawsuit

(Sharecast News) - GSK updated the market on the litigation regarding the now-discontinued heartburn drug ranitidine, or 'Zantac', on Friday.

Read more
23 Jun 2023 08:23

TOP NEWS: GSK reaches settlement in California Zantac lawsuit

(Alliance News) - GSK PLC on Friday said a Zantac trial set to begin next month in California has been dismissed after it reached a confidential settlement.

Read more
23 Jun 2023 08:19

Europe open: Stocks on the defensive after weak PMIs, euro awalloped

(Sharecast News) - Stocks on the Continent were trading on the back foot following the release of much weaker than expected readings for euro area factory and services activity.

Read more
23 Jun 2023 07:58

LONDON BRIEFING: GSK settles Zantac litigation in California

(Alliance News) - Stocks in London are set to open in the red on Friday, as risk sentiment across the globe is damped by hawkish central banks.

Read more
23 Jun 2023 07:42

European stocks head for worst week since March

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

EUROPEAN STOCKS HEAD FOR WORST WEEK SINCE MARCH (0638 GMT)

Read more
22 Jun 2023 09:26

GSK says Arexvy recommended in over 60s by US CDC committee

(Alliance News) - GSK PLC on Thursday said the US Centers for Disease Control & Prevention's Advisory Committee on Immunization Practices has voted to recommend the firm's Arexvy jab in adults aged 60 and older.

Read more
22 Jun 2023 07:51

US CDC votes to recommend GSK's Arexvy against RSV

(Sharecast News) - America's public health watchdog endorsed GSK's Arexvy for use against Respiratory Syncytial Virus in adults over 60.

Read more
21 Jun 2023 23:10

US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSV

June 21 (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections be available to older adults in the U.S. but stopped short of saying all of them should get the shots.

Read more
21 Jun 2023 22:10

US CDC advisers back use of GSK, Pfizer RSV vaccines in older adults

June 21 (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that adults aged 60 and above may receive the recently approved vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections. (Reporting by Raghav Mahobe in Bengaluru and Michael Erman in New York; Editing by Leslie Adler)

Read more
21 Jun 2023 11:00

US CDC advisers weigh use of GSK, Pfizer RSV vaccines in older adults

June 21 (Reuters) - A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday will vote on whether to recommend the use of recently approved vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections in older adults.

Read more
21 Jun 2023 09:19

GSK unveils positive trial results for vaccine against RSV

(Sharecast News) - GSK unveiled unveiled successful third phase clinical trial results for its Arexvy vaccine against respiratory syncytial virus in older adults.

Read more
21 Jun 2023 08:20

TOP NEWS: GSK reports positive data for RSV Arexvy vaccine

(Alliance News) - GSK PLC on Wednesday reported positive data for Arexvy, its respiratory syncytial virus vaccine for older adults.

Read more
20 Jun 2023 17:20

Miners, oil drag London stocks lower after modest China rate cut

Miners down as metal prices fall on strong dollar, China worries

*

Read more
20 Jun 2023 08:33

Lab crunch: British science has nowhere to go

OXFORD, England, June 20 (Reuters) - For Ros Deegan, the thrill of raising $100 million to expand a biotech firm among the dreaming spires of Oxford was soon tempered: unable to find a bigger laboratory, she routinely had to work at home.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.